initial public offerings (IPOs) trading on American exchanges

Thursday, June 19, 2014

Lumenis (LMNS) began trading on the NASDAQ on 27 February 2014

Lumenis Ltd. is a provider of energy-based, minimally invasive clinical solutions. The Company operated in three segments: surgical, ophthalmic and aesthetic. It provides energy-based solutions for both medically necessary and elective procedures, primarily for the aging population. Its focused product offerings provide solutions for a range of minimally invasive procedures. Its solutions include its VersaPulse PowerSuite platform using high-powered holmium lasers for urologic applications, its M22 multi-energy, multi-application platform for the treatment of various skin conditions, and its Selecta multi-modality platform for retinal, secondary cataract and glaucoma therapies. Its primary target markets for its products are hospitals, outpatient clinics, ambulatory surgery centers, physicians’ offices, private clinics and aesthetic chains.


6 Hakidma Street Yokneam Industrial Park, P.O.B. 240
YOKNEAM, 2069204

Website links

Key stats and ratios

Q4 (Dec '13)2013
Net profit margin6.61%6.55%
Operating margin8.86%9.65%
EBITD margin-9.36%
Return on average assets9.31%8.88%
Return on average equity123.60%198.75%

No comments:

Post a Comment